Fulcrum Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Fulcrum Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2020 to Q3 2024.
  • Fulcrum Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 1.95K %, a 11.1% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 1.95K +195 +11.1% Sep 30, 2024
Q2 2024 1.96K +277 +16.5% Jun 30, 2024
Q1 2024 1.89K +546 +40.7% Mar 31, 2024
Q4 2023 1.91K +787 +69.9% Dec 31, 2023
Q3 2023 1.76K +645 +57.9% Sep 30, 2023
Q2 2023 1.68K +628 +59.5% Jun 30, 2023
Q1 2023 1.34K +349 +35.1% Mar 31, 2023
Q4 2022 1.13K +247 +28% Dec 31, 2022
Q3 2022 1.11K +421 +60.7% Sep 30, 2022
Q2 2022 1.06K +519 +96.9% Jun 30, 2022
Q1 2022 994 +399 +67.2% Mar 31, 2022
Q4 2021 880 +301 +52% Dec 31, 2021
Q3 2021 693 +17.1 +2.52% Sep 30, 2021
Q2 2021 536 -333 -38.3% Jun 30, 2021
Q1 2021 594 -232 -28.1% Mar 31, 2021
Q4 2020 579 Dec 31, 2020
Q3 2020 676 Sep 30, 2020
Q2 2020 869 Jun 30, 2020
Q1 2020 827 Mar 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.